|  | Population1 |  | |||||
---|---|---|---|---|---|---|---|---|
Haplotype | Acetylation activity2 | FBAN | FTIN | FADE | FBON | DAZ | KANE | Total |
NAT2*4 | fast | 2 | 4 | 6 | 8 | 7 | 2 | 29 |
NAT2*4a | fast | Â | Â | Â | Â | Â | 1 | 1 |
NAT2*12A | fast | 6 | 5 | Â | 4 | 11 | 6 | 32 |
NAT2*13A | fast | 11 | 10 | 8 | 7 | 2 | 2 | 40 |
NAT2*5A | slow | Â | 1 | Â | 1 | Â | 3 | 5 |
NAT2*5B | slow | 39 | 46 | 42 | 47 | 28 | 40 | 242 |
NAT2*5Ba 3 | slow | Â | Â | 2 | 1 | Â | 1 | 4 |
NAT2*5C | slow | 3 | 4 | 6 | 2 | 1 | 3 | 19 |
NAT2*6A | slow | 32 | 17 | 20 | 23 | 23 | 25 | 140 |
NAT2*6Aa 3 | slow | Â | Â | Â | Â | 1 | Â | 1 |
NAT2*6C | slow | Â | Â | Â | 1 | Â | Â | 1 |
NAT2*7B | slow | Â | 1 | Â | 2 | 2 | 2 | 7 |
NAT2*14A | slow | 2 | 4 | 7 | Â | 1 | Â | 14 |
NAT2*14B | slow | 3 | 5 | 2 | 2 | 1 | 5 | 18 |
NAT2*14Ba 3 | slow | Â | Â | 1 | Â | Â | Â | 1 |
NAT2*6F | unknown | Â | 1 | Â | Â | Â | Â | 1 |
NAT2*6O | unknown | Â | Â | Â | Â | 1 | 1 | 2 |
NAT2*12H | unknown | Â | Â | 2 | 1 | 4 | 7 | 14 |
NAT2*12N 4 | unknown | Â | 1 | Â | Â | Â | Â | 1 |
NAT2*13D 4 | unknown | Â | Â | Â | 1 | Â | Â | 1 |
NAT2*14K 4 | unknown | Â | 1 | Â | Â | Â | Â | 1 |
Total (2N chromosomes) | 98 | 100 | 96 | 100 | 82 | 98 | 574 | |
Number of haplotypes (k) | 8 | 13 | 10 | 13 | 12 | 13 | Â | |
Number of segregating sites (S) | 6 | 9 | 9 | 10 | 10 | 11 | Â | |
Gene diversity (expected heterozygosity, h) | 0.72 | 0.75 | 0.75 | 0.72 | 0.78 | 0.76 | Â | |
Nucleotide diversity (π) x 10−3 | 1.81 | 1.79 | 1.85 | 1.78 | 1.83 | 1.93 |  | |
Tajima’s D (P-value)5 | 2.65 (0.994) | 1.09 (0.875) | 1.18 (0.891) | 0.73 (0.801) | 0.72 (0.799) | 0.68 (0.875) |  |